Alveo Technologies develops and commercializes a portable molecular diagnostic platform that brings rapid, high-sensitivity pathogen detection out of centralized laboratories and into the field. Its flagship Alveo Sense™ system combines patented electrical sensing and molecular amplification to deliver accurate results in under an hour, with cloud connectivity for real-time data and surveillance. The platform is used across animal health, agriculture, food safety, environmental monitoring, and human health to enable earlier detection and faster response. By decentralizing molecular diagnostics, Alveo aims to make high-quality testing more accessible, scalable, and actionable at the point of need.

‍